• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚(丙交酯-乙交酯)薄膜和颗粒中质量传递阻力的发展 - 一项机理研究。

Development of mass transport resistance in poly(lactide-co-glycolide) films and particles--a mechanistic study.

机构信息

Department of Chemical Engineering, Lund University, P.O. Box 124, SE-221 00 Lund, Sweden.

出版信息

Int J Pharm. 2011 May 16;409(1-2):194-202. doi: 10.1016/j.ijpharm.2011.02.066. Epub 2011 Mar 8.

DOI:10.1016/j.ijpharm.2011.02.066
PMID:21392561
Abstract

Poly(D,L-lactide-co-glycolide) (PLG) is the most frequently used biodegradable polymer in the controlled release of an encapsulated drug. The purpose of this work was to explain the surprisingly slow diffusion through this polymer, and locate the major source of mass transport resistance. Diffusion of human growth hormone (hGH) and glucose through PLG films was undetectable (using a diffusion cell), although the degraded polymer contained several times more water than polymer mass. In vitro release of hGH from PLG-coated particles also showed a surprisingly slow rate of release. Non-porous regions inside the PLG films were detected after three weeks of degradation using dextran-coupled fluorescent probes and confocal microscopy. The findings were supported by scanning electron microscopy. Diffusion through PLG films degraded for five weeks was significantly increased when the porosity of both surfaces was increased due to the presence of ZnCl(2) in the buffer the last 3 days of the degradation period. The results indicated high mass transport resistance inside the films after three weeks of degradation, and at the surfaces after five weeks of degradation. These results should also be applicable to microparticles of different sizes. Knowledge of the reason for transport resistance is important in the development of pharmaceuticals and when modifying the rate of drug release.

摘要

聚(D,L-丙交酯-co-乙交酯)(PLG)是在包封药物的控制释放中最常使用的可生物降解聚合物。本工作的目的是解释通过这种聚合物的扩散速度为何出人意料地慢,并找出主要的传质阻力源。尽管降解后的聚合物所含的水量比聚合物的质量多几倍,但人生长激素(hGH)和葡萄糖通过 PLG 膜的扩散是无法检测到的(使用扩散池)。PLG 包衣颗粒中 hGH 的体外释放也显示出出人意料的缓慢释放速率。使用葡聚糖偶联荧光探针和共焦显微镜在降解三周后检测到 PLG 膜内的非多孔区域。扫描电子显微镜的结果也支持这一发现。降解五周后的 PLG 膜的扩散在最后 3 天降解缓冲液中存在 ZnCl2 时,由于两面的多孔性增加而显著增加。结果表明,降解三周后膜内的传质阻力很大,降解五周后在膜表面的传质阻力也很大。这些结果也应该适用于不同大小的微球。了解传质阻力的原因对于药物的开发和药物释放速率的调节非常重要。

相似文献

1
Development of mass transport resistance in poly(lactide-co-glycolide) films and particles--a mechanistic study.聚(丙交酯-乙交酯)薄膜和颗粒中质量传递阻力的发展 - 一项机理研究。
Int J Pharm. 2011 May 16;409(1-2):194-202. doi: 10.1016/j.ijpharm.2011.02.066. Epub 2011 Mar 8.
2
Encapsulated zinc salt increases the diffusion of protein through PLG films.包封的锌盐增加了蛋白质通过聚乳酸-乙醇酸共聚物(PLG)薄膜的扩散。
Int J Pharm. 2009 Mar 31;370(1-2):47-53. doi: 10.1016/j.ijpharm.2008.11.017. Epub 2008 Nov 27.
3
Pore formation and pore closure in poly(D,L-lactide-co-glycolide) films.聚(D,L-丙交酯-共-乙交酯)薄膜中的孔形成和孔闭合。
J Control Release. 2011 Mar 10;150(2):142-9. doi: 10.1016/j.jconrel.2010.11.020. Epub 2010 Nov 19.
4
In vitro degradation of polyanhydride/polyester core-shell double-wall microspheres.聚酸酐/聚酯核壳双壁微球的体外降解
Int J Pharm. 2005 Sep 14;301(1-2):294-303. doi: 10.1016/j.ijpharm.2005.06.004.
5
Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.聚乳酸-羟基乙酸共聚物微球平均直径和多分散性对药物释放的影响:实验与理论
Int J Pharm. 2007 Jun 7;337(1-2):118-26. doi: 10.1016/j.ijpharm.2006.12.037. Epub 2007 Jan 7.
6
Fluphenazine release from biodegradable microparticles: characterization and modelling of release.从可生物降解的微球中释放奋乃静:释放的特性和建模。
J Microencapsul. 2009 Aug;26(5):403-10. doi: 10.1080/02652040802396575.
7
Controlled release of bioactive recombinant human growth hormone from PLGA microparticles.聚乳酸-乙醇酸共聚物(PLGA)微球中生物活性重组人生长激素的控释。
J Microencapsul. 2010;27(6):552-60. doi: 10.3109/02652048.2010.489974.
8
Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.开发一种新型制剂,其包含分散在聚乳酸-乙醇酸共聚物-聚乙二醇-聚乳酸-乙醇酸共聚物(PLGA-PEG-PLGA)凝胶中的聚(d,l-丙交酯-乙交酯)微球,用于更昔洛韦的持续递送。
J Control Release. 2005 Nov 28;108(2-3):282-93. doi: 10.1016/j.jconrel.2005.09.002. Epub 2005 Oct 17.
9
Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.小分子从聚(D,L-丙交酯)/聚(D,L-丙交酯-共-乙交酯)复合微粒中的释放
J Pharm Sci. 2005 Sep;94(9):2013-22. doi: 10.1002/jps.20408.
10
Adsorption of poly(ethylene glycol)-modified ribonuclease A to a poly(lactide-co-glycolide) surface.聚乙二醇修饰的核糖核酸酶A在聚(丙交酯-共-乙交酯)表面的吸附
Biotechnol Bioeng. 2005 Jun 30;90(7):856-68. doi: 10.1002/bit.20481.

引用本文的文献

1
Design of a Dual-Drug Delivery System for Local Release of Chlorhexidine and Dexketoprofen.用于氯己定和右酮洛芬局部释放的双药递送系统的设计
Polymers (Basel). 2025 Jun 26;17(13):1771. doi: 10.3390/polym17131771.
2
Physicochemical Characterization and Pharmacokinetics of Agomelatine-Loaded PLGA Microspheres for Intramuscular Injection.载阿戈美拉汀 PLGA 微球的理化性质表征及药代动力学研究。
Pharm Res. 2018 Nov 8;36(1):9. doi: 10.1007/s11095-018-2538-7.
3
Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a review.
自催化降解 PLGA 微球给药的数学模型——综述。
J Control Release. 2013 Jan 10;165(1):29-37. doi: 10.1016/j.jconrel.2012.10.015. Epub 2012 Oct 26.